拜玛林制药 内部交易概览
最近18个月交易的高管股东 | 交易次数 | 净买入(股) |
---|---|---|
Jean Jacques Bienaime | 18 | -295,000 |
Brian Mueller | 4 | -17,380 |
Jeffrey Robert Ajer | 4 | -61,000 |
George Eric Davis | 3 | -49,366 |
Henry J Fuchs | 2 | -47,341 |
V Bryan Lawlis | 1 | -8,500 |
交易分段汇总 | 买入数量 | 卖出数量 | 净买入(股) |
---|---|---|---|
最近1个月 | 0 | 66,888 | -66,888 |
最近3个月 | 0 | 139,229 | -139,229 |
最近6个月 | 0 | 182,993 | -182,993 |
最近12个月 | 0 | 316,353 | -316,353 |
最近18个月 | 3,625 | 482,233 | -478,608 |
最近36个月 | 3,625 | 557,154 | -553,529 |
拜玛林制药 内部交易
拜玛林制药 最新内部交易
Jean Jacques Bienaime | 董事 | 2024-04-12 | 卖出 | 40,000 | 722,527 |
$91.13
|
-11.21%
|
Erin Burkhart | GVP, Chief Accounting Officer | 2024-04-10 | 卖出 | 2,286 | 16,156 |
$90
|
-10.10%
|
George Eric Davis | EVP, Chief Legal Officer | 2024-03-28 | 卖出 | 24,602 | 55,856 |
$88.34
|
-8.41%
|
Jean Jacques Bienaime | 董事 | 2024-03-06 | 卖出 | 2,000 | 807,736 |
$86.11
|
-6.04%
|
Jeffrey Robert Ajer | EVP, Chief Commercial Officer | 2024-03-05 | 卖出 | 4,000 | 94,047 |
$87.07
|
-7.07%
|
Henry J Fuchs | President, Worldwide R&D | 2024-03-05 | 卖出 | 35,341 | 212,117 |
$85.18
|
-5.01%
|
Jean Jacques Bienaime | 董事 | 2024-02-27 | 卖出 | 1,000 | 809,736 |
$90.35
|
-10.45%
|
Jean Jacques Bienaime | 董事 | 2024-02-09 | 卖出 | 30,000 | 667,135 |
$89.03
|
-9.12%
|
Jean Jacques Bienaime | 董事 | 2024-01-10 | 卖出 | 20,000 | 672,695 |
$97.29
|
-16.84%
|
Jean Jacques Bienaime | 董事 | 2023-12-21 | 卖出 | 10,000 | 672,645 |
$93.99
|
-13.92%
|